Could treatment with botulinum toxin protect against subsequent infection with COVID-19? - 01/04/22
, P.J. Finiels b, S. Galmiche a, P. Jammet a, M. de Boutray a
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Abstract |
We report comparative results, over three months, of the impact of SARS-CoV2 in our patients injected with botulinum toxin for functional purposes, compared to the general population. Botulinum neurotoxin type A (BoNT/A) is known to block acetylcholine (ACh) as well as many other neuroreceptors and neuromodulators. The recent mention of a potential protective effect of nicotine in COVID 19, by blocking ACh, attracted our attention and guided the present study.
Our results show a significant difference between the number of infected individuals in the general population and the number of patients injected with BoNT/A who showed signs of COVID 19.
Le texte complet de cet article est disponible en PDF.Keywords : COVID-19, Botulinum toxin, Acetylcholine blocking
Plan
Vol 123 - N° 2
P. 98-100 - avril 2022 Retour au numéro
Article précédent
- Secondary thrombocytopenia after SARS-CoV-2 vaccine: Report of a case of hemorrhage and hematoma after minor oral surgery
- Luigi Angelo Vaira, Luigi Podda, Piero Doneddu, Maria Grazia Careddu, Claudio Fozza, Giacomo De Riu
- Impact of the COVID-19 pandemic upon patients with burning mouth syndrome
- Castillo-Felipe Candela, Lope-Jornet Pia, Eduardo Pons-Fuster, Asta Tvarijonaviciute
Bienvenue sur EM-consulte, la référence des professionnels de santé.